653 search results for “hybrid drug” in the Student website
-
Hybrid workshop: Narrating Highland Heritages of Bhutan
Lecture, Hybrid workshop
-
Roxanne Kieltyka -
Doing Drugs Responsibly! A Primer
Workshop
-
Serkan Aslan -
Sebastian Pomplun -
Coen van Hasselt -
Anthe Janssen -
Major study offers practical guidance on antibiotic dosing in patients with obesity
Leiden researcher Anne-Grete Märtson brought together a large number of studies to better understand antibiotic dosing in patients with obesity. The publication in a renowned medical journal has already garnered much positive reactions, Märtson says. ‘It’s high time researchers started sharing more…
-
Over a million euros for two studies on solutions to antimicrobial resistance
Two consortia led by Leiden researchers have been awarded over one million euros by the Dutch Research Council and the Ministry of Health, Welfare and Sport to find solutions to antimicrobial resistance.
-
Leiden scientists join national effort to advance nanomedicine
A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University play a key role in the project.
-
How Oncode-PACT is bringing new cancer medicines closer with 325 million in Growth Fund money
How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…
-
Seeking new concepts to treat diseases
Scientific Director of the Leiden Academic Centre for Drug Research (LACDR) Hubertus Irth: ‘We test substances and look for new concepts for treating disease.’
-
Thomas Hankemeier -
Leiden ‘super antibiotic’ keeps dangerous gut bacterium under control with a low dose
The antibiotic EVG7, developed in Leiden, has proven capable of fighting the dangerous gut bacterium C. difficile with only a minimal dose. What’s more, the bacterium is far less likely to return, a major issue with existing antibiotics. The research was published in Nature Communications.
-
‘Never stop trying’: Barz sees his polymers enter clinical trials
A new class of polymers has been used in patients for the first time. The compound is the first new drug solubilising agent in decades. Introduced in 2014 by chemist Matthias Barz from Leiden University, it offers a unique alternative to current options.
-
Olivier Béquignon -
Agreements
Read here about the various agreements in place at Leiden University for student and study associations and other student organisations.
-
During the next pandemic, this mathematical model will speed up the search for treatment
Do you recall all those drugs that were hastily proposed as potential treatments for COVID-19? In the event of a future pandemic, the goal is to offer an effective treatment more quickly and efficiently. To achieve this, a team led by Coen van Hasselt is developing a platform that can speed up the process…
-
Medical Delta AI for Computational Life Sciences
The fact that scientists are increasingly better able to access molecular cell and tissue data also brings with it a new challenge: how can scientists find the information they need for research among the vast amount of data available?
-
CANCELLED: Gloves are off: When and why allies use cyber weapons in hybrid scenarios?
Lecture
-
Kim Elbertse -
Elsa Neubert -
Andraniek Evadgian -
Daisy Batenburg -
Irene Pascual Garcia -
Myrtille Koerselman -
Kostas Tassis
-
Leo Price
-
Marc Boef
-
Bola Khalil -
Matthijs Vlasveld -
Daan Jiskoot -
Rosan Kuin -
Nasi Liu -
Mark Fonteyne
-
Martijn Moné
-
Martin Sicho -
Nada Badr
-
Linde Schoenmaker -
Rob van Wijk -
Annaloes Fokkelman-Klip -
Kirsten Veltman -
Xiaobing Zhang -
Lukas Wijaya -
Sabine de Winter -
Linglu Xu -
Britt Duijndam -
Lucy Sinke -
Mick van Schaick -
Natasha Tahir